Array BioPharma, Inc. Logo Image

Array BioPharma, Inc.

Array BioPharma, Inc. Banner Image

Most Recent Annual Report

2018 Annual Report and Form 10K

Array BioPharma, Inc.


Array BioPharma, Inc. does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Array BioPharma, Inc.

201-500 Employees
Based in Boulder, Colorado

Array BioPharma Inc. is a fully integrated biopharmaceutical company focused on the discovery, development and commercialization of transformative and well-tolerated targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. Array markets BRAFTOVIĀ® (encorafenib) capsules in combination with MEKTOVIĀ® (binimetinib) tablets for the treatment of patients with unresectable or metastatic melanoma with a BRAFV600E or BRAFV600K mutation in the United States and with partners in other major worldwide markets.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol